Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study investigates if prior SARS-CoV-2 infection increases sensitivity to toxin that induces parkinsonism

A recent study explored whether individuals who have recovered from mild to moderate or severe COVID-19 may have an increased risk for developing Parkinson’s disease in the future.

7 Feb 2022

Cerebrovascular impairment persists months after severe acute COVID-19, UK study

Researchers in the United Kingdom have conducted an observational cohort study on hospitalized patients and have found that the degree of severity of acute coronavirus disease 2019 (COVID-19) predicts the occurrence of chronic cerebrovascular impairment. The study further suggests that the levels of cerebrovascular impairment are associated with worse cognitive, mental, and physical well-being.

7 Feb 2022

USP22 crucial for type III interferon signaling and SARS-CoV-2 infection

In a recent study posted to the bioRxiv* pre-print server, a team of researchers demonstrated that ubiquitin-specific peptidase 22 (USP22) is a crucial regulator of basal interferon (IFN) signaling in native human intestinal epithelial cells (hIECs).

7 Feb 2022

Study looks at rapid antigen vs. PCR tests in the emergency department triage

In a recent study posted to the Lancet preprint* server, researchers assessed the utility of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) rapid antigen testing (RAT) for patient triage in the hospital emergency department (ED).

7 Feb 2022

Booster vaccines found to augment T-cell responses to SARS-CoV-2 Omicron

In a recent study published in the latest issue of the journal Cell, a team of researchers evaluated T-cell reactivity to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant's spike (S) and non-spike proteins.

6 Feb 2022

Sentinel cards found to be effective for indoor SARS-CoV-2 monitoring

In a recent study posted to the bioRxiv* preprint server, a team of researchers used sentinel cards for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) monitoring in schools where individual-level sampling is tedious due to privacy or compliance reasons and higher cost.

6 Feb 2022

Vaccine-induced immunity and prior infection effective in reducing COVID severity in reinfections

A recent study posted to the Research Square* preprint server and under consideration for inclusion in the journal Scientific Reports assessed the epidemiology of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) reinfections.

6 Feb 2022

Northwestern researchers study COVID-19 mechanisms, infection patterns and impact on gender minorities

Northwestern Medicine investigators continue to study the COVID-19 pandemic, from the biological mechanisms of disease and infection patterns to the pandemic's impact on women and sexual and gender minorities.

6 Feb 2022

Researchers discover a new function of anti-HIV-1 antibodies

Teams at the Institut Pasteur, CNRS, Vaccine Research Institute (VRI) and Université de Paris have discovered a new function of anti-HIV-1 antibodies by applying cutting-edge microscopy techniques to in vitro viral cultures.

6 Feb 2022

A novel approach to predict mutations within the SARS-CoV-2 spike

A study posted recently to the bioRxiv* preprint server demonstrated that the emergence of new spike variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) can be predicted.

6 Feb 2022

Detection of SARS-CoV-2 Delta variant infection in a domestic cat

The first published case describing the Delta variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a domestic cat in the United States highlights the realistic scenario of spillover infections with emerging viral variants that threaten human and animal health.

6 Feb 2022

Study examines community and individual risk factors that relate to higher risk of COVID-19

Black residents of Baton Rouge and New Orleans faced twice the risk of SARS-CoV-2 infection as white residents, a study shows.

6 Feb 2022

Assessing public trust and understanding of CDC’s revised COVID-19 guidelines

Researchers assess the understanding and trust of the revised COVID-19 isolation and quarantine guidance recommended by the U.S. CDC.

6 Feb 2022

Booster dose of Pfizer-BioNTech COVID vaccine protects elderly against Omicron

Researchers discuss the impact of mRNA booster immunization on the neutralizing activity against the SARS-CoV-2 Omicron variant in the elderly.

6 Feb 2022

Women, smokers and drinkers more likely to develop taste or smell disorders from COVID

Researchers investigate the relationship between TSD and COVID-19.

6 Feb 2022

Greater neutralizing titers observed in vaccinated individuals with breakthrough Omicron infection

Researchers assess the neutralizing power of plasma samples collected from Omicron convalescent individuals who were either vaccinated or unvaccinated.

6 Feb 2022

Many COVID-19 patients still contagious after five days

A new study shows that a high proportion of individuals still test positive for SARS-CoV-2 infection using RATs after five days of quarantine.

6 Feb 2022

Dizziness is a common symptom of COVID-19

New research published in Internal and Emergency Medicine discusses the relationship between SARS-CoV-2 infection and dizziness.

6 Feb 2022

Study finds increased vaccine breakthrough, less hospitalization rates and disease severity in omicron patients

Within only three weeks after the omicron variant was first identified among Houston Methodist patients, this variant rapidly took over and became the cause of a majority of new cases.

4 Feb 2022

Cognitive shortcuts may promote unsafe behaviors during the COVID-19 pandemic

If close friends and family members who contracted COVID-19 had mild cases and recovered quickly, or if they had an adverse reaction to the vaccine, your brain might convince you that you'd have the same experience.

4 Feb 2022

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study investigates if prior SARS-CoV-2 infection increases sensitivity to toxin that induces parkinsonism

Cerebrovascular impairment persists months after severe acute COVID-19, UK study

USP22 crucial for type III interferon signaling and SARS-CoV-2 infection

Study looks at rapid antigen vs. PCR tests in the emergency department triage

Booster vaccines found to augment T-cell responses to SARS-CoV-2 Omicron

Sentinel cards found to be effective for indoor SARS-CoV-2 monitoring

Vaccine-induced immunity and prior infection effective in reducing COVID severity in reinfections

Northwestern researchers study COVID-19 mechanisms, infection patterns and impact on gender minorities

Researchers discover a new function of anti-HIV-1 antibodies

A novel approach to predict mutations within the SARS-CoV-2 spike

Detection of SARS-CoV-2 Delta variant infection in a domestic cat

Study examines community and individual risk factors that relate to higher risk of COVID-19

Assessing public trust and understanding of CDC’s revised COVID-19 guidelines

Booster dose of Pfizer-BioNTech COVID vaccine protects elderly against Omicron

Women, smokers and drinkers more likely to develop taste or smell disorders from COVID

Greater neutralizing titers observed in vaccinated individuals with breakthrough Omicron infection

Many COVID-19 patients still contagious after five days

Dizziness is a common symptom of COVID-19

Study finds increased vaccine breakthrough, less hospitalization rates and disease severity in omicron patients

Cognitive shortcuts may promote unsafe behaviors during the COVID-19 pandemic

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in